Metagenomi science chief departs, just a few months after IPO

The chief scientific officer at gene editing company Metagenomi is out, the company confirmed to Endpoints News.

“As of yesterday, I have parted ways with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

What’s Driving Healthcare Consolidation? The Answer May Surprise You

WASHINGTON — What is driving consolidation in healthcare? The answer is: consolidation, Erin Fuse Brown, JD, MPH, said Tuesday. “If all of the other competitors

May 22, 2024

LightOx Accelerate R&D using A4I – Lifescience Industry News

LightOx, based in Newcastle, has developed a UK-first solution for early-stage mouth cancers using light-activated chemotherapy. The treatment involves a gel being applied to the

July 12, 2023

ICER revises sickle cell gene therapy report, preps to dig into what CMS negotiations might look like

The Boston-based Institute for Clinical and Economic Review, a drug price watchdog, has revised its report on sickle cell gene therapies and is planning a

July 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.